West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 716,600 | 708,700 | 686,900 | 771,300 | 720,000 |
| Cost of Goods | 445,300 | 446,600 | 418,900 | 449,800 | 435,400 |
| Gross Profit | 271,300 | 262,100 | 268,000 | 321,500 | 284,600 |
| Operating Expenses | 116,300 | 133,000 | 82,700 | 93,900 | 95,300 |
| Operating Income | 155,300 | 129,700 | 186,200 | 228,400 | 189,700 |
| Interest Expense | 2,200 | 1,700 | 2,200 | 1,800 | 2,200 |
| Other Income | 10,500 | 3,900 | -43,000 | 6,100 | 7,500 |
| Pre-tax Income | 163,600 | 131,900 | 141,000 | 232,700 | 195,000 |
| Income Tax | 23,600 | 28,900 | 20,400 | 44,200 | 21,200 |
| Net Income Continuous | 140,000 | 103,000 | 120,600 | 188,500 | 173,800 |
| Net Income | $140,000 | $103,000 | $120,600 | $188,500 | $173,800 |
| EPS Basic Total Ops | 1.88 | 1.38 | 1.62 | 2.53 | 2.34 |
| EPS Basic Continuous Ops | 1.88 | 1.38 | 1.62 | 2.53 | 2.34 |
| EPS Diluted Total Ops | 1.85 | 1.37 | 1.59 | 2.48 | 2.29 |
| EPS Diluted Continuous Ops | 1.85 | 1.36 | 1.59 | 2.49 | 2.29 |
| EBITDA(a) | $186,900 | $160,800 | $216,000 | $258,500 | $219,300 |